Background: The agouti yellow mouse shows adult onset of moderate obesity and diabetes. A depressed basal lipolytic rate in adipocytes or a decreased adrenergic tone arising from antagonizing a-melanocyte-stimulating hormone (MSH) activation of melanocortin receptors (MCR) could be at the origin of the obesity phenotype.
INTRODUCTION
Obesity, which has become a prominent health problem in North American societies (1) , has a polygenic and multifactorial origin (2) . Animal models of obesity in rodents (3) , such as those arising spontaneously or resulting from specific rodent crosses, could help to understand the causes of obesity. Among the single-gene mouse mutation models of obesity, the agouti yellow (AY) mouse shows adult onset of moderate obesity arising from excess fat in all depots, from hyperphagia, insulin resistance, glucose intolerance, and diabetes (4) . Agouti mRNA has been shown to be expressed exclusively in the skin of 664 Molecular Medicine, Volume 3, Number 10, October 1997 neonatal mice (5) , and the ectopic expression of agouti produces the obesity phenotype (6) . Moreover, it has been shown that agouti-specific expression in adipose tissue in mouse indicated obesity (7) . The human homolog of agouti, renamed agouti signaling protein (ASP) gene (8) , or ASIP, has been reported to be expressed in adipose tissue and testis (9) , in heart, ovary, and, at a lower level, in liver and kidney (8) . The ASIP gene has been located on human 20ql 1.2, but no significant linkage or association has been reported between markers in the proximity of the ASIP locus and obesity (10, I 1).
In mice, it has been hypothesized that the effect of agouti could be mediated via the regulation of intracellular Ca21 levels ([Ca2+] i) in skeletal muscle whereby an increase in [Ca2+]i could lead to insulin resistance, hyperinsulinemia, and obesity (12, 13) . Other mechanisms that have been proposed to explain the obesity phenotype in these mice include a depressed basal lipolytic rate in adipocytes resulting from altered intracellular cAMP levels, or a decreased adrenergic tone that may trigger hyperphagia and increased efficiency of food utilization-both mechanisms arising from antagonizing a-melanocyte-stimulating hormone (MSH) activation of melanocortin receptors (6) .
Five melanocortin receptors (MC 1 R to MC5R) have been identified so far in mouse and human. These receptors show various binding properties with their ligands, together with specific tissue expressions, the latter being less well characterized in humans. Agouti shifts the MSH functional curve of these receptors without affecting maximal activation, which suggests that agouti acts as a competitive antagonist inhibiting agonist binding (14) . MC3R and MC5R are not antagonized by agouti in rodents (14) , but human HEK-293 cells transfected with MC3R
showed an increase in [Ca2+]i in the presence of agouti (15) . MC4R is clearly antagonized by human agouti (14) , and it has been shown that the intracerebroventricular administration of an agonist of MC4R, as well as of MC3R, inhibits feeding in four mouse models of hyperphagia, including agouti; this shows that these receptors exert a tonic inhibitory effect on feeding behavior (16) . Moreover, knockout mice for MC4R recapitulate several aspects of the agouti obesity syndrome, including hyperphagia, hyperinsulinemia, and late-onset obesity (17) .
We have uncovered new restriction fragment-length polymorphisms (RFLP) for the melanocortin receptors 4 and 5, and we report here on linkage and association of these receptors with obesity-related phenotypes in subjects from the Quebec Family Study (QFS). Adiposity, energy metabolism, and insulin and glucose homeostasis-related variables were analyzed. We also examined the mRNA tissue expression in humans of the MCR family genes.
MATERIALS AND METHODS Subjects and Phenotypes
The QFS cohort has been previously described (18) . Normal-weight, overweight, and obese subjects from Caucasian nuclear families of French descent from the greater Quebec City area were tested for a battery of morphometric and physiologic variables. At Table 1 . Relatively low variation was observed for MC5R polymorphisms (frequencies of 95% and 89% for the most frequent alleles), which is slightly raised by using MC5R haplotypes (frequency of 84% for the most frequent haplotype). Accordingly, the heterozygosity level for these polymorphisms was increased from 0. The mean and range of the different phenotypic variables are shown in Table 2 for each of the sex-by-generation groups. Subjects ranged in age from 18 (Figure 2 ). However, this mRNA was hard to detect, as reamplification was necessary to obtain a clear signal.
In Figure 3 , the distribution of the other four (Fig. 3) . Recent data showed that the knockout of this gene in mouse recapitulates several aspects of agouti obesity syndromes (17) and that intracerebroventricular administration of a specific agonist of , 671 MC4R inhibits feeding behavior in mouse models of hyperphagia (16) . These data argue in favor of a central effect of agouti on MC4R, but a peripheral effect on adipose tissue cannot be ruled out, particularly since agouti is expressed in adipose tissue and strongly antagonizes MC4R (14) .
In conclusion, significant linkages and associations were observed between MC5R and adiposity-related variables, whereas associations were observed for MC4R. We have examined the tissue distribution of the various receptors and have found that they are expressed in tissues (mainly brain, adipose, skeletal muscle) that play a role in energy balance. These results, together with those obtained recently in transgenic and knockout mice, confirm that these two MCR genes are important candidates for the obesity phenotype expression in humans. The different MCR alleles showing linkage and association in humans need to be further characterized in the search for the specific molecular variations in the MCR genes that influence body weight and fat deposition.
